SeraCare posts $1.07 million August net operating income

By Caroline Salls

Pittsburgh, Sept. 21 - SeraCare Life Sciences, Inc. reported a net operating income of $1.07 million for August on $4.49 million in sales, according to its monthly operating report filed Thursday with the U.S. Bankruptcy Court for the Southern District of California.

The figures compare to a $379,795 July net operating loss on $2.8 million in sales.

The net loss for August was $729,434, improved from a $1.4 million July net loss.

Cash and cash equivalents on Aug. 31 were $14.87 million, compared with $18.68 million at the end of July.

SeraCare, an Oceanside, Calif., manufacturer and provider of biological products and services to diagnostic, therapeutic, drug discovery and research organizations, filed for bankruptcy on March 22. Its Chapter 11 case number is 06-00510.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.